News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
367,192 Results
Type
Article (15144)
Company Profile (114)
Press Release (351934)
Section
Business (113568)
Career Advice (460)
Deals (18738)
Drug Delivery (29)
Drug Development (31942)
Employer Resources (50)
FDA (8855)
Job Trends (7753)
News (174471)
Policy (12536)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1364)
Allergies (38)
Alliances (34973)
ALS (22)
Alzheimer's disease (505)
Antibody-drug conjugate (ADC) (61)
Approvals (8876)
Artificial intelligence (225)
Autoimmune disease (2)
Automation (11)
Bankruptcy (132)
Best Places to Work (6587)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (86)
Bladder cancer (21)
Brain cancer (11)
Breast cancer (108)
Cancer (947)
Cardiovascular disease (58)
Career advice (410)
Career pathing (8)
CAR-T (97)
Cell therapy (264)
Cervical cancer (10)
Clinical research (24914)
Collaboration (566)
Compensation (108)
Complete response letters (3)
COVID-19 (1352)
CRISPR (34)
C-suite (129)
Cystic fibrosis (48)
Data (894)
Decentralized trials (1)
Denatured (18)
Depression (15)
Diabetes (93)
Diagnostics (4937)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (73)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (21)
Earnings (38826)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51507)
Executive appointments (359)
FDA (9429)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (453)
Gene editing (80)
Generative AI (23)
Gene therapy (160)
GLP-1 (226)
Government (1313)
Grass and pollen (1)
Guidances (23)
Healthcare (9975)
Huntington's disease (5)
IgA nephropathy (9)
Immunology and inflammation (27)
Indications (11)
Infectious disease (1423)
Inflammatory bowel disease (60)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (56)
Interviews (51)
IPO (8060)
IRA (9)
Job creations (1451)
Job search strategy (366)
Kidney cancer (3)
Labor market (9)
Layoffs (118)
Leadership (3)
Legal (2537)
Liver cancer (35)
Lung cancer (121)
Lymphoma (55)
Machine learning (2)
Management (17)
Manufacturing (166)
MASH (15)
Medical device (11472)
Medtech (11477)
Mergers & acquisitions (10997)
Metabolic disorders (204)
Multiple sclerosis (24)
NASH (3)
Neurodegenerative disease (24)
Neuropsychiatric disorders (4)
Neuroscience (679)
NextGen: Class of 2025 (3549)
Non-profit (1537)
Northern California (1023)
Now hiring (8)
Obesity (88)
Opinion (78)
Ovarian cancer (42)
Pain (44)
Pancreatic cancer (38)
Parkinson's disease (61)
Partnered (11)
Patents (128)
Patient recruitment (48)
Peanut (26)
People (33075)
Pharmaceutical (16)
Phase I (9175)
Phase II (11262)
Phase III (7311)
Pipeline (463)
Podcasts (36)
Policy (27)
Postmarket research (520)
Preclinical (4119)
Press Release (66)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (158)
Rare diseases (131)
Real estate (3386)
Recruiting (20)
Regulatory (9428)
Reports (20)
Research institute (1307)
Resumes & cover letters (68)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (11)
Series A (82)
Series B (49)
Service/supplier (7)
Sickle cell disease (16)
Southern California (1100)
Special edition (1)
Spinal muscular atrophy (62)
Sponsored (13)
Startups (2526)
State (2)
Stomach cancer (2)
Supply chain (22)
The Weekly (17)
United States (10768)
Vaccines (338)
Venture capitalists (19)
Webinars (7)
Weight loss (36)
Women's health (17)
Worklife (2)
Date
Today (52)
Last 7 days (270)
Last 30 days (1283)
Last 365 days (17861)
2025 (4101)
2024 (18882)
2023 (22286)
2022 (31083)
2021 (32820)
2020 (30870)
2019 (25988)
2018 (19601)
2017 (19095)
2016 (17924)
2015 (20748)
2014 (15327)
2013 (12843)
2012 (13897)
2011 (14191)
2010 (12910)
Location
Africa (329)
Alabama (37)
Alaska (6)
Arizona (118)
Arkansas (10)
Asia (24079)
Australia (4197)
California (2664)
Canada (980)
China (224)
Colorado (154)
Connecticut (131)
Delaware (36)
Europe (50700)
Florida (456)
Georgia (130)
Idaho (33)
Illinois (263)
India (10)
Indiana (151)
Iowa (4)
Japan (98)
Kansas (80)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (438)
Massachusetts (1873)
Michigan (180)
Minnesota (240)
Mississippi (2)
Missouri (56)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (66)
New Jersey (839)
New Mexico (16)
New York (792)
North Carolina (501)
North Dakota (7)
Northern California (1023)
Ohio (100)
Oklahoma (11)
Oregon (20)
Pennsylvania (561)
Puerto Rico (8)
Rhode Island (20)
South America (512)
South Carolina (16)
South Dakota (1)
Southern California (1100)
Tennessee (54)
Texas (434)
Utah (97)
Virginia (52)
Washington D.C. (11)
Washington State (310)
West Virginia (3)
Wisconsin (35)
367,192 Results for "oxford nanopore technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Oxford Nanopore Technologies Collaborates With Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine
Oxford Nanopore Technologies announced the launch of a new Pharmacogenomics Beta Program to advance personalised medicine, combining Twist Bioscience’s next generation sequencing target enrichment technology with Oxford Nanopore’s sequencing platform.
May 22, 2024
·
3 min read
Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
Oxford Nanopore Technologies plc, the company delivering a new generation of nanopore-based molecular sensing technology, and SeqOne, the leading AI-driven genomic decision support software, announced a new partnership enabling end-to-end analytical workflows from sample to report, focusing on rare diseases in the short-term and oncology in the longer-term.
March 11, 2024
·
5 min read
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Oxford Nanopore launches PromethION 2 Integrated into open early access
Oxford Nanopore Technologies announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated to complete its PromethION product range.
March 7, 2024
·
3 min read
Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing
Oxford Nanopore Technologies plc, the company delivering a new generation of nanopore-based molecular sensing technology, and Saphetor, the next generation sequencing data analysis company, announce a new partnership to support the comprehensive analysis of nanopore sequencing data and to enable end-to-end workflows.
October 25, 2023
·
5 min read
Press Releases
Wasatch BioLabs and Oxford Nanopore Team Up to Accelerate Methylation Sequencing Towards Clinical Use
November 4, 2024
·
5 min read
Press Releases
Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK
November 5, 2024
·
8 min read
Press Releases
Oxford Nanopore and UK Biobank to create world’s first epigenetic dataset targeting the causes of cancer, dementia, complex disease
November 27, 2024
·
10 min read
Press Releases
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
October 18, 2024
·
3 min read
BioMidwest
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, unveiled a multi-year joint development collaboration to develop new clinical tests for diseases and improve patient care.
October 19, 2023
·
3 min read
1 of 36,720
Next